NCT00018382已完成2 期
Insulin, Neurogenetics and Memory in Alzheimer's Disease: A Novel Therapeutic Approach
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 试验地点
- 2
研究概览
简要总结
This study examines the use of insulin-sensitizing compounds, as therapeutic agents for cognitive impairment in Alzheimer's disease.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 55 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
Memory and Insulin in Early Alzheimer's DiseaseAlzheimer's DiseaseNCT00581867Jeff Burns, MD31
已完成
不适用
Mechanisms of Insulin Facilitation of MemoryMemory DisordersNCT01145482University of Texas at Austin12
招募中
不适用
Brain Insulin Resistance in Mild Cognitive ImpairmentAlzheimer DiseaseMild Cognitive ImpairmentPositron Emission TomographyNCT06116188Turku University Hospital40
已完成
4 期
Insulin Resistance and Central Nervous System (CNS) Function in Type 2 DiabetesType 2 Diabetes MellitusInsulin ResistanceNCT00212290National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)140
撤回
不适用
Investigating Brain Insulin Resistance in Alzheimer Disease with IntraNasal Insulin : a Multimodal Neuroimaging StudyAlzheimer DiseaseMild Cognitive ImpairmentNCT06391853Erasme University Hospital120